advertisements
20.08.2024
Defense System Engineer – TelecomSecurity
Italy, Firenze
... Engineer in both Customer and RD contexts, particularly for Defense business. Hereafter the main related responsibilities are listed: To scout continuously the Defense Market and the Thales Products Portfolio in order to find innovative solutions, following especially the digital transformation ...
More »
Thales Italia S.P.A.
20.08.2024
STEM IT - Proposal Land Installation Engineer
Italia, Milano PPL
... Engineering and other Departments, as required, on the chosen solution Participation to clarifications meetings both internal and with Customer during tender preparation Site visits, if necessary, to understand logistic aspects of the job, check feasibility of solutions, contacting potential ...
More »
IT1510 Prysmian Power Link Srl
12.08.2024
AFBC Officer (m/w/d)
Germany, Frankfurt Taunusanlage 12
... standards anwenden, um den Erfolg der DB bei der Bekämpfung der Finanzkriminalität zu gewährleisten. Teambeschreibung Anti-Fraud, Bribery Corruption (AFBC) verantwortet den Schutz der Deutschen Bank vor Risiken, die sich aus Betrug, Bestechung und Korruption sowie damit verwandten ...
More »
0010 Deutsche Bank Aktiengesellschaft
12.08.2024
Avionic Design Engineer
Ireland, Dublin, Ireland
... Engineer Do you have a background in Avionics / aircraft electrical engineering and would like to join our growing Part 21 Design department? CAE are presently accepting applications for Avionic Design Engineer role within our Part 21J Design department. We have a position for engineer with ...
More »
08 CAE Parc Aviation
20.08.2024
Attaché à la Promotion du Médicament BPCO Bourgogne Franche Comté H/F
France, Field Worker - FRA
Attaché(e) à la Promotion du médicament H/F Le Laboratoire GlaxoSmithKline (GSK) recherche un(e) Attaché(e) à la Promotion du Médicament dans le domaine du respiratoire, la BPCO plus précisément, en exclusivité chez les pneumologues libéraux et hospitaliers dans le cadre d’un CDI. Le poste est ...
More »
2332 Laboratoire GlaxoSmithKline S.A.S.